Table 4.
Response given (%) | Total (N = 8768) | France (n = 1665) | Germany (n = 2326) | Italy (n = 1680) | Spain (n = 1534) | UK (n = 1563) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ST | HM | ST | HM | ST | HM | ST | HM | ST | HM | ST | HM | |
Staging at diagnosis | 38 | 65 | 41 | 74 | 31 | 75 | 39 | 57 | 37 | 52 | 45 | 68 |
Bone pain | 35 | 36 | 48 | 52 | 20 | 7 | 34 | 37 | 37 | 46 | 42 | 34 |
Routine metastases screening | 25 | 5 | 14 | 2 | 41 | 12 | 30 | 6 | 21 | 7 | 6 | 1 |
Investigation following an eventa | 7 | 18 | 9 | 20 | 5 | 10 | 6 | 23 | 5 | 20 | 9 | 13 |
Hypercalcaemia | 5 | 9 | 6 | 15 | 3 | 1 | 4 | 7 | 5 | 9 | 6 | 13 |
Accidental discovery | 5 | 3 | 5 | 1 | 5 | 1 | 5 | 3 | 6 | 9 | 4 | 1 |
Otherb | 3 | 0 | 6 | 0 | 0 | 0 | 3 | 0 | 4 | 0 | 3 | 0 |
HM, haematological malignancy; PSA, prostate‐specific antigen; ST, solid tumour.
Events included confirmed or suspected pathologic fracture or spinal compression.
Including increase in tumour markers (e.g. PSA), check on spread of metastases/restaging for any metastases, extensive examination after finding lumps, worsening of general condition and pain. Investigators could give more than one response.